Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Buy
65
TOI Quote, Financials, Valuation and Earnings
Last price:
$1.78
Seasonality move
:
-29.37%
Day range:
$1.62 - $1.80
52-week range:
$0.13 - $1.80
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.34x
P/B ratio:
43.77x
Volume:
700.2K
Avg. volume:
752K
1-year change:
29.71%
Market cap:
$157.1M
Revenue:
$393.4M
EPS (TTM):
-$0.71
Earnings Data
Next earnings date for TOI
May 14
2025
Most recent earnings per share
-$0.14
Missed by $0.14
(Mar 24/2025)
Consensus Estimate
--
(Mar 24/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
TOI Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 03/24/2025 | Q4 | -- | $100.3M | -$0.14 | -- | -- |
| 11/13/2024 | Q3 | -- | $99.9M | -$0.18 | -- | -- |
| 08/13/2024 | Q2 | $103.3M | $98.6M | -$0.17 | -$0.10 | -$0.07 |
| 05/14/2024 | Q1 | $95.2M | $94.7M | -$0.22 | -$0.12 | -$0.10 |
| 03/27/2024 | Q4 | $82M | $85.8M | -$0.21 | -$0.11 | -$0.10 |
| 11/08/2023 | Q3 | $74.7M | $82M | -$0.19 | -$0.13 | -$0.06 |
| 08/08/2023 | Q2 | $73.8M | $80.2M | -$0.19 | -$0.17 | -$0.02 |
| 05/10/2023 | Q1 | $65M | $76.2M | -$0.33 | -- | -- |
| 03/09/2023 | Q4 | $64.7M | $71.4M | -$0.15 | -$0.20 | $0.05 |
| 11/09/2022 | Q3 | $69M | $65M | -$0.17 | -$0.18 | $0.01 |
| 08/09/2022 | Q2 | -- | $60.9M | -$0.06 | -- | -- |
| 05/11/2022 | Q1 | -- | $55.2M | $0.21 | -- | -- |
| 03/10/2022 | Q4 | -- | $52.3M | -$0.15 | -- | -- |
| 09/30/2021 | Q3 | -- | $52.3M | -$0.04 | -- | -- |
| 06/30/2021 | Q2 | -- | $49.8M | $0.05 | -- | -- |
| 03/31/2021 | Q1 | -- | $48.6M | -$0.02 | -- | -- |
| 12/31/2020 | Q4 | -- | $187.5M | -$0.13 | -- | -- |
| 09/30/2020 | Q3 | -- | -- | -$0.08 | -- | -- |
| 06/30/2020 | Q2 | -- | $47.3M | $0.02 | -- | -- |
| 12/31/2018 | Q4 | -- | $37.4M | -$0.03 | -- | -- |
The Oncology Institute Earnings Questions
-
How Much did The Oncology Institute Generate in Revenue Last Quarter?
The Oncology Institute reported $100.3M worth of top line sales in its most recent quarter.
-
Did The Oncology Institute Beat Earnings Last Quarter?
The Oncology Institute announced earnings per share of -$0.14 which represents a miss of analyst forecast a -- per share.
-
Is The Oncology Institute Profitable?
The Oncology Institute reported $14.6M that represents $0.19 per share over the last quarter.
-
What is the Analyst Consensus for The Oncology Institute EPS Next Year?
The Oncology Institute's earnings are forecast to decrease from -$0.71 per share to -$0.51 per share next year representing a decrease of -54.35%.
-
When is The Oncology Institute's Earnings Date?
The Oncology Institute's next earnings date is May 14, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Is Bloom Energy Stock a Buy, Sell or Hold?
While already interesting as the world moves toward greener energy…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
